1Spokojny AM, Sanborn TA. Management of the arterial puncture site[J]. J Intervent Cardiol,1994,7:187 - 193.
2Heintzen MP, Strauer BE. Peripheral arterial complications after heart catheterization[J]. Herz, 1998,23:4 -20.
3EPIC investigators. Use of monoclonal antibody directed against the platelet glycoprotein (GP) Ⅱb,/Ⅲa receptor in high risk coronary angioplasty[J]. N Engl J Med, 1994, 330:956 -961.
4Exaire JE, Dauerman HL, Topol EJ, et al. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices[J]. Am Heart J, 2004,147(1) :31 -34.
5Cote HA. Closure of the femoral vein puncture site after transcatheter procedures using Anglo - Seal [J]. Catheter Cardiovasc Interv ,2002,55(1) :16 -19.
7Wu CJ,Lo PH,Chang KC,et al.Transradial coronary angioplaphy and angioplasty in Chinese patients[J].Cathet Cardiovasc Diagn,1997,40:159-163.
8Hildick-Smith D,Walsh JT,Lowe MD,et al.Coronary angiography in the fully anticoagulated patient:the transradial route is successful and safe[J].Cathet Cardiovasc Intervent,2003,58:8-10.
9Cooper CS,E1 shiekh RA,Cohen DJ,et al.Effect of transradial access on quality of life and cost of cardiac catheterization:a randomized comparison[J].Am Heart J,1999,138:430-436.
